oncology research

LEXINGTON, Mass., May 11, 2026 Partner Therapeutics, Inc. (PTx) announced that the U.S. Food and Drug Administration (FDA) has...

SAN FRANCISCO and SUZHOU, China, May 10, 2026 Innovent Biologics, Inc. announced that China’s National Medical Products Administration (NMPA)...

BOSTON, May 5, 2026 Sensei Biotherapeutics, Inc. has announced the first patient dosing in its Phase 1b/2 clinical trial...

PARIS, France and CAMBRIDGE, Mass., United States – May 4, 2026 Nanobiotix has announced FDA acceptance of a protocol...

OXFORD, UK, April 28, 2026 Scancell Holdings plc, a clinical-stage biopharmaceutical company specializing in cancer immunotherapies, has reported significant...

San Diego, California, USA – April 22, 2026 In a significant development in oncology drug innovation, Phanes Therapeutics has...

London, United Kingdom | April 13, 2026 GSK plc has announced positive clinical data from its Phase 1 BEHOLD-1...

TAIPEI, Taiwan, April 13, 2026 AnBogen Therapeutics has announced that its lead investigational therapy Imofinostat (ABT-301) will be featured...

Tel Aviv, Israel & Tokyo, Japan | April 9, 2026 Imagene AI has announced a strategic collaboration with Daiichi...

INGELHEIM, Germany, April 9, 2026 Boehringer Ingelheim has announced a strategic clinical trial collaboration with BioNTech to evaluate a...